These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12897465)

  • 1. Effects of an angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitors on burst forming units-erythroid in chronic hemodialysis patients.
    Naito M; Kawashima A; Akiba T; Takanashi M; Nihei H
    Am J Nephrol; 2003; 23(5):287-93. PubMed ID: 12897465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II stimulates proliferation of normal early erythroid progenitors.
    Mrug M; Stopka T; Julian BA; Prchal JF; Prchal JT
    J Clin Invest; 1997 Nov; 100(9):2310-4. PubMed ID: 9410909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of angiotensin II type I receptor on erythroid progenitors of patients with post transplant erythrocytosis.
    Gupta M; Miller BA; Ahsan N; Ulsh PJ; Zhang MY; Cheung JY; Yang HC
    Transplantation; 2000 Oct; 70(8):1188-94. PubMed ID: 11063339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of erythropoietin, angiotensin II, and angiotensin-converting enzyme inhibitor on erythroid precursors in patients with posttransplantation erythrocytosis.
    Glicklich D; Kapoian T; Mian H; Gilman J; Tellis V; Croizat H
    Transplantation; 1999 Jul; 68(1):62-6. PubMed ID: 10428268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of angiotensin II receptor blockade on the interaction between enalaprilat and doxazosin in rat tail arteries.
    Marwood JF
    Clin Exp Pharmacol Physiol; 1998; 25(7-8):517-21. PubMed ID: 9673422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibitor therapy in chronic hemodialysis patients: any evidence of erythropoietin resistance?
    Cruz DN; Perazella MA; Abu-Alfa AK; Mahnensmith RL
    Am J Kidney Dis; 1996 Oct; 28(4):535-40. PubMed ID: 8840943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II increases erythropoietin production in healthy human volunteers.
    Freudenthaler SM; Schreeb K; Körner T; Gleiter CH
    Eur J Clin Invest; 1999 Oct; 29(10):816-23. PubMed ID: 10583422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematocrit-lowering effect following inactivation of renin-angiotensin system with angiotensin converting enzyme inhibitors and angiotensin receptor blockers.
    Marathias KP; Agroyannis B; Mavromoustakos T; Matsoukas J; Vlahakos DV
    Curr Top Med Chem; 2004; 4(4):483-6. PubMed ID: 14965314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin converting enzyme inhibitors impair recombinant human erythropoietin induced erythropoiesis in patients with chronic renal failure.
    Qureshi IZ; Abid K; Ambreen F; Qureshi AL
    Saudi Med J; 2007 Feb; 28(2):193-6. PubMed ID: 17268695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of angiotensin II receptor AT1 subtypes in renal afferent arterioles during chronic changes in sodium diet.
    Ruan X; Wagner C; Chatziantoniou C; Kurtz A; Arendshorst WJ
    J Clin Invest; 1997 Mar; 99(5):1072-81. PubMed ID: 9062366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy.
    Suzuki H; Kanno Y; Kaneko K; Kaneko M; Kotaki S; Mimura T; Takane H
    Ther Apher Dial; 2004 Aug; 8(4):320-7. PubMed ID: 15274684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guinea pig serum erythropoietin (EPO) selectively stimulates guinea pig erythroid progenitors: human or mouse erythroid progenitors do not form erythroid burst-forming unit colonies in response to guinea pig serum EPO.
    Stopka T; Zivny JH; Goldwasser E; Prchal JF; Necas E; Prchal JT
    Exp Hematol; 1998 Aug; 26(9):910-4. PubMed ID: 9694513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
    Akagi S; Ichikawa H; Okada T; Sarai A; Sugimoto T; Morimoto H; Kihara T; Yano A; Nakao K; Nagake Y; Wada J; Makino H
    J Am Soc Nephrol; 2004 Dec; 15(12):3215-24. PubMed ID: 15579525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perturbation of autocrine/paracrine loops of burst-forming units of erythroid-derived cells in rHuEPO-hyporesponsive hemodialysis patients.
    Nakao K; Wada J; Ota K; Ichikawa H; Akagi S; Okamoto A; Hida K; Nagake Y; Makino H
    Am J Kidney Dis; 2003 Mar; 41(3):624-36. PubMed ID: 12612986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Worsening of anemia by angiotensin converting enzyme inhibitors and its prevention by antiestrogenic steroid in chronic hemodialysis patients.
    Onoyama K; Sanai T; Motomura K; Fujishima M
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S27-30. PubMed ID: 2474097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enalaprilat, losartan and LU 135252 in coronary blood flow regulation.
    Rigol M; Heras M; Solanes N; Epelde F; Roig E; Pérez-Villa F; Roqué M; Sanz G
    Eur J Clin Invest; 2003 May; 33(5):363-9. PubMed ID: 12713448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of ACE inhibitors versus AT1 blockers.
    Vaughan D
    Can J Cardiol; 2000 Aug; 16 Suppl E():36E-40E. PubMed ID: 10906625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low doses of losartan and trandolapril improve arterial stiffness in hemodialysis patients.
    Ichihara A; Hayashi M; Kaneshiro Y; Takemitsu T; Homma K; Kanno Y; Yoshizawa M; Furukawa T; Takenaka T; Saruta T
    Am J Kidney Dis; 2005 May; 45(5):866-74. PubMed ID: 15861352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effects of ACE inhibitor treatment and ACE gene polymorphism on erythropoiesis in chronic hemodialysis patients].
    Hatano M; Yoshida T; Mimuro T; Kimata N; Tsuchiya K; Sanaka T; Nihei H
    Nihon Jinzo Gakkai Shi; 2000 Oct; 42(8):632-9. PubMed ID: 11195399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effect of desferrioxamine and recombinant erythropoietin on erythroid precursor proliferation in chronic renal failure.
    Aucella F; Vigilante M; Scalzulli P; Musto P; Prencipe M; Valente GL; Carotenuto M; Stallone C
    Nephrol Dial Transplant; 1999 May; 14(5):1171-5. PubMed ID: 10344357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.